ST. LOUIS, May 16, 2012 /PRNewswire/ -- Sigma-Aldrich announced today that it has established a new $600 million revolving credit facility that will mature on May 10, 2017. The new facility replaces a $450 million revolving credit facility that was scheduled to mature on December 11, 2012. The $600 million facility will provide back-up liquidity for the commercial paper program and be used for general corporate purposes.
Wells Fargo Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC served as co-lead arrangers for the nine-bank syndicate participating in this facility. Wells Fargo Bank, National Association acted as the administrative agent.
About Sigma-Aldrich: Sigma-Aldrich (Ticker SIAL) is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university and government institutions, hospitals and industry. The Company operates in 40 countries and has nearly 9,000 employees whose objective is to provide excellent service worldwide. Sigma-Aldrich is committed to accelerating customer success through innovation and leadership in Life Science and High Technology. For more information about Sigma-Aldrich, please visit its website at http://www.sigma-aldrich.com/.